A Study Regarding Tissue Response During and After Treatment for Anal Cancer
Recruiting · NCT05939401 · Observational (researchers observe without assigning treatment) · Lead sponsor: Sahlgrenska University Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Biopsies
What this trial is about
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Newly diagnosed or recurrent anal cancer
Exclusion criteria
- No diagnosis of anal cancer, contraindication to biopsies and blood samples
Where it is running
2 locations listed.
- Dept. of Surgery, Sahlgrenska University Hospital/Ostra - Gothenburg, Sweden
- Sahlgrenska University Hospital - Gothenburg, Sweden